Search
Add filters:
Use filters to refine the search results.
Results 1-5 of 5 (Search time: 0.051 seconds).
- previous
- 1
- next
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| Feb-2019 | Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial | Vachiéry, Jean-Luc; Galiè, Nazzareno; Barberà i Mir, Joan Albert; Frost, Adaani E.; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M; McLaughlin, Vallerie V.; Peacock, Andrew J.; Simonneau, Gérald; Blair, Christiana; Miller, Karen L.; Langley, Jonathan; Rubin, Lewis J.; AMBITION Investigators |
| 27-Aug-2015 | Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension | Galiè, Nazzareno; Barberà i Mir, Joan Albert; Frost, Adaani E.; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M; McLaughlin, Vallerie V.; Peacock, Andrew J.; Simonneau, Gérald; Vachiéry, Jean-Luc; Grünig, Ekkehard; Oudiz, Ronald J.; Vonk-Noordegraaf, Anton; White, R. James; Blair, Christiana; Gillies, Hunter; Miller, Karen L.; Harris, Julia H. N.; Langley, Jonathan; Rubin, Lewis J.; AMBITION Investigators |
| 1-Dec-2019 | Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial | McLaughlin, Vallerie V.; Vachiéry, Jean-Luc; Oudiz, Ronald J.; Rosenkranz, Stephan; Galiè, Nazzareno; Barberà i Mir, Joan Albert; Frost, Adaani E.; Ghofrani, Hossein-Ardeschir; Peacock, Andrew J.; Simonneau, Gérald; Rubin, Lewis J.; Blair, Christiana; Langley, Jonathan; Hoeper, Marius M; AMBITION Investigators |
| 12-Sep-2019 | Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension | White, R. James; Vonk-Noordegraaf, Anton; Rosenkranz, Stephan; Oudiz, Ronald J.; McLaughlin, Vallerie V.; Hoeper, Marius M; Grünig, Ekkehard; Ghofrani, Hossein-Ardeschir; Chakinala Murali M.; Barberà i Mir, Joan Albert; Blair, Christiana; Langley, Jonathan; Frost, Adaani E. |
| 30-Dec-2016 | Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial | Coghlan, John Gerry; Galiè, Nazzareno; Barberà i Mir, Joan Albert; Frost, Adaani E.; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M; Kuwana, Masataka; McLaughlin, Vallerie V.; Peacock, Andrew J.; Simonneau, Gérald; Vachiéry, Jean-Luc; Blair, Christiana; Gillies, Hunter; Miller, Karen L.; Harris, Julia H. N.; Langley, Jonathan; Rubin, Lewis J.; AMBITION Investigators |
Discover
Subject